PHARMA-BIO SERV, INC.: 10-Q filed 2019-09-16
What PHARMA-BIO SERV, INC. reported in its quarterly report filed 2019-09-16 (fiscal Q3 2019): 32 published measures, 120 facts as tagged in accession 0001654954-19-010776.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2019-09-16
- Fiscal period
- fiscal Q3 2019
- Accession
- 0001654954-19-010776 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PHARMA-BIO SERV, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 26,251,082 | USD | |
| At 2018-10-31 | 25,378,312 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 4,460,391 | USD | |
| At 2018-10-31 | 5,114,649 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 21,790,691 | USD | |
| At 2019-04-30 | 21,357,422 | USD | |
| At 2019-01-31 | 20,685,771 | USD | |
| At 2018-10-31 | 20,263,663 | USD | |
| At 2018-07-31 | 18,717,926 | USD | |
| At 2018-04-30 | 18,021,543 | USD | |
| At 2018-01-31 | 18,168,440 | USD | |
| At 2017-10-31 | 20,747,286 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 14,795,694 | USD | |
| At 2019-04-30 | 15,433,111 | USD | |
| At 2018-10-31 | 16,029,920 | USD | |
| At 2018-07-31 | 15,118,539 | USD | |
| At 2018-04-30 | 12,916,944 | USD | |
| At 2017-10-31 | 11,591,548 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-05-01 to 2019-07-31 | 431,158 | USD | 92 |
| 2018-11-01 to 2019-07-31 | 1,609,661 | USD | 273 |
| 2019-02-01 to 2019-04-30 | 707,483 | USD | 89 |
| 2018-11-01 to 2019-01-31 | 471,020 | USD | 92 |
| 2018-05-01 to 2018-07-31 | 730,631 | USD | 92 |
| 2017-11-01 to 2018-07-31 | -2,061,729 | USD | 273 |
| 2018-02-01 to 2018-04-30 | -128,348 | USD | 89 |
| 2017-11-01 to 2018-01-31 | -2,664,012 | USD | 92 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-05-01 to 2019-07-31 | -627,300 | USD | 92 |
| 2018-11-01 to 2019-07-31 | -1,667,929 | USD | 273 |
| 2018-05-01 to 2018-07-31 | 1,685,270 | USD | 92 |
| 2017-11-01 to 2018-07-31 | 3,261,777 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-05-01 to 2019-07-31 | 9,402 | USD | 92 |
| 2018-11-01 to 2019-07-31 | 48,246 | USD | 273 |
| 2018-05-01 to 2018-07-31 | 0 | USD | 92 |
| 2017-11-01 to 2018-07-31 | 57,764 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-05-01 to 2019-07-31 | 4,966,519 | USD | 92 |
| 2018-11-01 to 2019-07-31 | 14,683,060 | USD | 273 |
| 2018-05-01 to 2018-07-31 | 4,631,303 | USD | 92 |
| 2017-11-01 to 2018-07-31 | 12,123,257 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 20,720,769 | USD | |
| At 2018-10-31 | 19,111,111 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-05-01 to 2019-07-31 | 22,996,169 | shares | 92 |
| 2018-11-01 to 2019-07-31 | 23,045,432 | shares | 273 |
| 2018-05-01 to 2018-07-31 | 23,062,531 | shares | 92 |
| 2017-11-01 to 2018-07-31 | 23,076,306 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-05-01 to 2019-07-31 | 23,038,236 | shares | 92 |
| 2018-11-01 to 2019-07-31 | 23,108,752 | shares | 273 |
| 2018-05-01 to 2018-07-31 | 23,074,606 | shares | 92 |
| 2017-11-01 to 2018-07-31 | 23,080,758 | shares | 273 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-05-01 to 2019-07-31 | 11,382 | USD | 92 |
| 2018-11-01 to 2019-07-31 | 129,595 | USD | 273 |
| 2018-05-01 to 2018-07-31 | 52,966 | USD | 92 |
| 2017-11-01 to 2018-07-31 | 2,753,989 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 306,817 | USD | |
| At 2018-10-31 | 298,020 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-05-01 to 2019-07-31 | 9,000 | USD | 92 |
| 2018-11-01 to 2019-07-31 | 27,000 | USD | 273 |
| 2019-02-01 to 2019-04-30 | 9,000 | USD | 89 |
| 2018-11-01 to 2019-01-31 | 9,000 | USD | 92 |
| 2018-05-01 to 2018-07-31 | 17,550 | USD | 92 |
| 2017-11-01 to 2018-07-31 | 52,650 | USD | 273 |
| 2018-02-01 to 2018-04-30 | 17,550 | USD | 89 |
| 2017-11-01 to 2018-01-31 | 17,550 | USD | 92 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-05-01 to 2019-07-31 | 431,158 | USD | 92 |
| 2018-11-01 to 2019-07-31 | 1,609,661 | USD | 273 |
| 2018-05-01 to 2018-07-31 | 721,819 | USD | 92 |
| 2017-11-01 to 2018-07-31 | -1,759,178 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 24,326,718 | USD | |
| At 2018-10-31 | 23,411,797 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 2,102,549 | USD | |
| At 2018-10-31 | 2,565,672 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 7,802,447 | USD | |
| At 2018-10-31 | 5,193,385 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-05-01 to 2019-07-31 | 572 | USD | 92 |
| 2018-11-01 to 2019-07-31 | 87,891 | USD | 273 |
| 2018-05-01 to 2018-07-31 | 0 | USD | 92 |
| 2017-11-01 to 2018-07-31 | 13,659 | USD | 273 |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-05-01 to 2019-07-31 | 1,565,924 | USD | 92 |
| 2018-11-01 to 2019-07-31 | 4,638,386 | USD | 273 |
| 2018-05-01 to 2018-07-31 | 1,593,848 | USD | 92 |
| 2017-11-01 to 2018-07-31 | 3,812,386 | USD | 273 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-05-01 to 2019-07-31 | 3,400,595 | USD | 92 |
| 2018-11-01 to 2019-07-31 | 10,044,674 | USD | 273 |
| 2018-05-01 to 2018-07-31 | 3,037,455 | USD | 92 |
| 2017-11-01 to 2018-07-31 | 8,310,871 | USD | 273 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-05-01 to 2019-07-31 | 1,205,228 | USD | 92 |
| 2018-11-01 to 2019-07-31 | 3,368,261 | USD | 273 |
| 2018-05-01 to 2018-07-31 | 1,170,134 | USD | 92 |
| 2017-11-01 to 2018-07-31 | 3,207,096 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 22,995,881 | shares | |
| At 2018-10-31 | 23,058,413 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 86,205 | USD | |
| At 2018-10-31 | 107,947 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 483,983 | USD | |
| At 2018-10-31 | 496,953 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 367,547 | USD | |
| At 2018-10-31 | 418,495 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-05-01 to 2019-07-31 | 442,540 | USD | 92 |
| 2018-11-01 to 2019-07-31 | 1,739,256 | USD | 273 |
| 2018-05-01 to 2018-07-31 | 774,785 | USD | 92 |
| 2017-11-01 to 2018-07-31 | 994,811 | USD | 273 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-05-01 to 2019-07-31 | 424,841 | USD | 92 |
| 2018-11-01 to 2019-07-31 | 1,587,919 | USD | 273 |
| 2018-05-01 to 2018-07-31 | 678,833 | USD | 92 |
| 2017-11-01 to 2018-07-31 | -2,068,351 | USD | 273 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-05-01 to 2019-07-31 | 25,121 | USD | 92 |
| 2018-11-01 to 2019-07-31 | 73,803 | USD | 273 |
| 2018-05-01 to 2018-07-31 | 20,480 | USD | 92 |
| 2017-11-01 to 2018-07-31 | 64,737 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-05-01 to 2019-07-31 | 81,844 | USD | 92 |
| 2018-11-01 to 2019-07-31 | 469,131 | USD | 273 |
| 2018-05-01 to 2018-07-31 | 351,071 | USD | 92 |
| 2017-11-01 to 2018-07-31 | 389,521 | USD | 273 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-05-01 to 2019-07-31 | 1,096 | USD | 92 |
| 2018-11-01 to 2019-07-31 | 3,000 | USD | 273 |
| 2018-05-01 to 2018-07-31 | 519 | USD | 92 |
| 2017-11-01 to 2018-07-31 | 1,610 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-05-01 to 2019-07-31 | 1,136,992 | USD | 92 |
| 2018-11-01 to 2019-07-31 | 2,610,837 | USD | 273 |
| 2018-05-01 to 2018-07-31 | -961,673 | USD | 92 |
| 2017-11-01 to 2018-07-31 | -1,948,132 | USD | 273 |
Inspect the source
- Entity
- PHARMA-BIO SERV, INC. / CIK 0001304161
- Captured
- 2026-09-19T11:17:27.241Z
- SEC response SHA-256
bc9f33e072a9daa74aa0e8c41fbfef83d107920bc25647db80386f28787f2d49
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001304161.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))